Clinical Trial Update: TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Tarus Therapeutics has withdrawn its TT-4 single-agent trial in advanced solid tumors across Phase 1 and Phase 2. The listed conditions include colorectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Hepatocellular Carcinoma
• Pancreatic Cancer

Drugs mentioned

• TT-4

Snippet

Sponsor: Tarus Therapeutics, Inc. | Conditions: Colorectal Cancer, Gastric Cancer | Phase 1, Phase 2 | Status: WITHDRAWN